AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Eve Health Ltd

0.023

0.000

Volume:- -

Turnover:- -

Market Cap:6.55M

PE:-2.00

High:0.023

Open:0.023

Low:0.023

Close:0.023

52wk High:0.040

52wk Low:0.022

Shares:284.88M

Float Shares:135.49M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.012

EPS(LYR):-0.011

ROE:-60.84%

ROA:-27.34%

PB:1.84

PE(LYR):-2.00

Loading ...

Overview Company News Filings

BRIEF-Eve Health Signs Telehealth Services Agreement With Hubmed

Eve Health Group Ltd-Medical Science Liaison Appointed

THOMSON REUTERS

BRIEF-Eve Health Group Raises A$1.1 MLN At A$0.030 Per Share

Eve Health Group - Raises a$1.1M at a$0.030 per Share

THOMSON REUTERS

BRIEF-Eve Health Group Requests Trading Halt For Capital Raising

EVE Health Group Confirms First Australian Prescriptions of Dyspro, Launches Support Platform

Why Investors Can’t Miss Spark Plus Australian Equities Day 2025

EVE Health Group Commences Distribution of Dyspro Gummies to Treat Period Pain

ASX Small-Cap Stocks to Watch

MT Newswires Live

EVE Health Group Appoints First Member of New Scientific Advisory Board

BRIEF-EVE Health Confirms Australian Regulatory Path For Initial Access To ED & Dysmenorrhoea Products

BUZZ-Australia's EVE Health Group jumps on snagging regulatory wins

ASX ALERT-EVE Submits First Commercial Purchase Order for Dyspro-EVE.AX

Application for quotation of securities - EVE-EVE.AX

Completion of Share Purchase Plan-EVE.AX

BRIEF-Eve Health Says Nextract Signed An Agreement With Teledocs Clinic & Consulting

EVE Investor Webinar-EVE.AX

EVE Health Group Completes Nextract Acquisition

MT Newswires Live

EVE Health Group Starts Stability Testing for Erectile Dysfunction, Dysmenorrhea Candidates

MT Newswires Live

BRIEF-Eve Health Seeks Trading Halt

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EVE.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EVE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EVE.AU\",,,,,undefined,":{"symbol":"EVE.AU","market":"AU","secType":"STK","nameCN":"Eve Health Ltd","latestPrice":0.023,"timestamp":1765861920000,"preClose":0.023,"halted":0,"volume":0,"delay":0,"nameEN":"Eve Health Ltd","floatShares":135489321,"shares":284876592,"eps":-0.011523,"marketStatus":"Closed","change":0,"latestTime":"12-16 16:12:00 AEDT","open":0.023,"high":0.023,"low":0.023,"amount":0,"amplitude":0,"askPrice":0.023,"askSize":644,"bidPrice":0.022,"bidSize":169826,"shortable":3,"etf":0,"ttmEps":-0.011523,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1765926000000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.023,"openAndCloseTimeList":[[1765839600000,1765861200000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EVE.AU\",,,,,undefined,":{"symbol":"EVE.AU","floatShares":135489321,"roa":"-27.34%","roe":"-60.84%","lyrEps":-0.011493,"shares":284876592,"dividePrice":0,"high":0.023,"amplitude":0,"preClose":0.023,"low":0.023,"week52Low":0.022,"pbRate":"1.84","psRate":"3.78","week52High":0.04,"institutionHeld":0,"latestPrice":0.023,"committee":0.992444,"eps":-0.011523,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.011523,"open":0.023,"prevYearClose":0.04,"prevWeekClose":0.024,"prevMonthClose":0.025,"prevQuarterClose":0.03,"fiveDayClose":0.025,"twentyDayClose":0.026,"sixtyDayClose":0.033,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EVE.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-06-02","symbol":"EVE.AU","defaultRemindTime":1748822400000,"type":"split","dateTimestamp":1748786400000,"forFactor":40,"toFactor":1,"ratio":40}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EVE.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EVE.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584678998","title":"BRIEF-Eve Health Signs Telehealth Services Agreement With Hubmed","url":"https://stock-news.laohu8.com/highlight/detail?id=2584678998","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584678998?lang=en_us&edition=fundamental","pubTime":"2025-11-19 09:16","pubTimestamp":1763514980,"startTime":"0","endTime":"0","summary":"BRIEF-Eve Health Signs Telehealth Services Agreement With HubmedNov 19 (Reuters) - Eve Health Group Ltd EVE.AX:SIGNS TELEHEALTH SERVICES AGREEMENT WITH HUBMEDFurther company coverage: EVE.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nFWN3WU18O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7141","EVE.AU"],"gpt_icon":0},{"id":"2580923930","title":"Eve Health Group Ltd-Medical Science Liaison Appointed","url":"https://stock-news.laohu8.com/highlight/detail?id=2580923930","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580923930?lang=en_us&edition=fundamental","pubTime":"2025-11-03 05:19","pubTimestamp":1762118350,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251102:nTUE1RFHGZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7141","EVE.AU"],"gpt_icon":0},{"id":"2574390035","title":"BRIEF-Eve Health Group Raises A$1.1 MLN At A$0.030 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2574390035","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574390035?lang=en_us&edition=fundamental","pubTime":"2025-10-09 09:42","pubTimestamp":1759974129,"startTime":"0","endTime":"0","summary":"BRIEF-Eve Health Group Raises A$1.1 MLN At A$0.030 Per ShareOct 9 (Reuters) - Eve Health Group Ltd EVE.AX:RAISES A$1.1M AT A$0.030 PER SHAREFurther company coverage: EVE.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nFWN3VP26Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVE.AU","BK7141"],"gpt_icon":0},{"id":"2574030799","title":"Eve Health Group - Raises a$1.1M at a$0.030 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2574030799","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574030799?lang=en_us&edition=fundamental","pubTime":"2025-10-09 06:25","pubTimestamp":1759962331,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nFWN3VP26Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EVE.AU","BK7141"],"gpt_icon":0},{"id":"2573897249","title":"BRIEF-Eve Health Group Requests Trading Halt For Capital Raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2573897249","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573897249?lang=en_us&edition=fundamental","pubTime":"2025-10-07 06:20","pubTimestamp":1759789253,"startTime":"0","endTime":"0","summary":"BRIEF-Eve Health Group Requests Trading Halt For Capital RaisingOct 7 (Reuters) - Eve Health Group Ltd EVE.AX:REQUESTS TRADING HALT FOR CAPITAL RAISINGFurther company coverage: EVE.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nFWN3VN1U4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7141","EVE.AU"],"gpt_icon":0},{"id":"2572555306","title":"EVE Health Group Confirms First Australian Prescriptions of Dyspro, Launches Support Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2572555306","media":"Small Caps","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572555306?lang=en_us&edition=fundamental","pubTime":"2025-10-01 08:24","pubTimestamp":1759278296,"startTime":"0","endTime":"0","summary":"EVE Health Group has prescribed its Dyspro cannabinoid-based gummy for the treatment of dysmenorrhoea and endometriosis to Australian patients for the first time.EVE issued the drug under the Therapeutic Goods Administration’s Special Access Scheme, marking the company’s transition from production and distribution to real-world patient access.The milestone follows the company’s successful completion of GMP manufacture and distribution, continuing EVE’s commercial rollout.EVE is progressing new partnerships to broaden its prescription and distribution channels, with the aim of scaling patient access and supporting future export opportunities.The company is also developing additional practitioner education initiatives to strengthen awareness and adoption across clinical networks, holding the first in-clinic seminar last week to demonstrate the therapeutic benefits of Dyspro and provide practical prescribing guidance.Prescription of Dyspro comes in parallel with the launch of theReclaim M","market":"us","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/EVE-Health-ASX-First-Australian-Prescriptions-Dyspro-Launches-Support-Platform.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/EVE-Health-ASX-First-Australian-Prescriptions-Dyspro-Launches-Support-Platform.jpg"],"rights":{"source":"smallcap_stock","url":"https://smallcaps.com.au/eve-health-group-first-australian-prescriptions-dyspro-launches-support-platform/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/eve-health-group-first-australian-prescriptions-dyspro-launches-support-platform/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["XJO.AU","BK7141","XAO.AU","EVE","EVE.AU","XKO.AU"],"gpt_icon":0},{"id":"2569275577","title":"Why Investors Can’t Miss Spark Plus Australian Equities Day 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2569275577","media":"Small Caps","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569275577?lang=en_us&edition=fundamental","pubTime":"2025-09-24 13:10","pubTimestamp":1758690649,"startTime":"0","endTime":"0","summary":"The Spark Plus Australian Equities Day 2025 is more than just another investor showcase—it’s your gateway to the next generation of ASX growth stories.Across 18 power-packed presentations, this event brings together some of Australia’s most ambitious companies, each sitting at the cutting edge of their sectors and driving innovation that matters.For investors in the region, this is an exclusive opportunity to connect directly with management teams, uncover high-potential opportunities, and gain exposure to the themes shaping global markets.Among the standouts, Harvest Technology  is redefining remote communications with its secure, low-bandwidth streaming technology, and is on track for profitability ahead of schedule.CurveBeam AI  is revolutionising orthopedic diagnostics with its pioneering 3D imaging systems gaining traction in global healthcare markets.Eve Health Group  is a next-generation healthcare provider leveraging telehealth, digital platforms, and patient-centric services t","market":"hk","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/09/Spark-Plus-Australian-Equities-Day-2025.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/09/Spark-Plus-Australian-Equities-Day-2025.jpg"],"rights":{"source":"smallcap_stock","url":"https://smallcaps.com.au/why-investors-cant-miss-spark-plus-australian-equities-day-2025/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/why-investors-cant-miss-spark-plus-australian-equities-day-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["BK4211","CVB.AU","TGM.AU","BK7007","XKO.AU","HTG.AU","BK7084","ISBC","XJO.AU","BK7016","BK7104","XAO.AU","BK7141","EVE.AU"],"gpt_icon":0},{"id":"2569279076","title":"EVE Health Group Commences Distribution of Dyspro Gummies to Treat Period Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2569279076","media":"Small Caps","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569279076?lang=en_us&edition=fundamental","pubTime":"2025-09-22 09:00","pubTimestamp":1758502812,"startTime":"0","endTime":"0","summary":"EVE Health Group  has commenced dispatching its proprietary women’s health product Dyspro to distribution partners in preparation for an Australian launch.Dyspro is a first-in-class, cannabinoid-based gummy for the symptoms of dysmenorrhoea  and endometriosis, two of the most prevalent and under-addressed conditions in women’s health.Following the completion of commercial-scale production, the product is now available for prescription under established regulatory pathways, with the company expecting first patient access shortly.EVE has established a national prescribing and education partnership with TeleDocs Clinic to provide streamlined access to Dyspro through its telehealth service, supported by a network of more than 3500 Australian pharmacies.EVE is evaluating additional prescription and distribution partnerships to diversify patient access pathways and support future export opportunities.EVE chief scientific officer Dr Stuart Gunzburg said the start of Dyspro sales would be a “m","market":"hk","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/09/EVE-Health-ASX-Distribution-Dyspro-Gummies-Treat-period-pain.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/09/EVE-Health-ASX-Distribution-Dyspro-Gummies-Treat-period-pain.jpg"],"rights":{"source":"smallcap_stock","url":"https://smallcaps.com.au/eve-health-group-distribution-dyspro-gummies-treat-period-pain/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/eve-health-group-distribution-dyspro-gummies-treat-period-pain/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["XJO.AU","EVE","EVE.AU","XKO.AU","XAO.AU","BK7141"],"gpt_icon":0},{"id":"2569275747","title":"ASX Small-Cap Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2569275747","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569275747?lang=en_us&edition=fundamental","pubTime":"2025-09-22 07:47","pubTimestamp":1758498431,"startTime":"0","endTime":"0","summary":"Investors are likely to keep their eyes peeled for the following small-cap stocks on the Australian Securities Exchange.EVE Health Group  said that Dyspto, its cannabinoid-based gummy for pain relief for women suffering from dysmenorrhea and endometriosis, can be prescribed via digital consults.Yandal Resources  said reverse circulation drilling at its Ironstone Well-Barwidgee project in Western Australia showed the capacity of the project to host a large-scale mineralized system.Morella  said ground gravity survey at the Mallina Lithium joint venture in Western Australia with Elevra Lithium  identified 12 new high-priority exploration targets with targets up to 100 meters wide and 450 meters long.DY6 Metals  said the soil sampling campaign at its Central Rutile Project in Cameroon has been expanded to include Yaounde West licences and now comprises 1,048 samples, of which 255 samples have been collected.Auric Mining  is set to start its first toll milling campaign at Black Cat Syndica","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","XJO.AU","YRL.AU","XKO.AU","BK7504","EVE.AU","DY6.AU","BK7104","AWJ.AU","BK7095","BC8.AU","1MC.AU","BK7141"],"gpt_icon":0},{"id":"2567790165","title":"EVE Health Group Appoints First Member of New Scientific Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2567790165","media":"Small Caps","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567790165?lang=en_us&edition=fundamental","pubTime":"2025-09-15 08:19","pubTimestamp":1757895576,"startTime":"0","endTime":"0","summary":"EVE Health Group  has appointed senior research scientist Dr Fiona Cousins as the inaugural member of its new scientific advisory board.Dr Cousins has more than a decade of experience in reproductive biology and women’s health research, and currently works at The Ritchie Centre within the Hudson Institute of Medical Research in Victoria, focusing on inflammation and its role in endometriosis pathogenesis and identifying new therapeutic targets for endometriosis treatment.She holds a PhD in reproductive biology from the University of Edinburgh and has published extensively on endometrial regulation and dysfunction and endometriosis disease pathogenesis.The appointment provides EVE with internationally-recognised expertise to help shape its research and development pipeline, with particular relevance to dysmenorrhoea  and endometriosis, which are among the most prevalent and under-addressed conditions affecting women’s health.The company has established the scientific advisory board to p","market":"hk","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/09/EVE-Health-Group-ASX-Appoints-First-Member-New-Scientific-Advisory-Board.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/09/EVE-Health-Group-ASX-Appoints-First-Member-New-Scientific-Advisory-Board.jpg"],"rights":{"source":"smallcap_stock","url":"https://smallcaps.com.au/eve-health-group-appoints-first-member-of-new-scientific-advisory-board/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/eve-health-group-appoints-first-member-of-new-scientific-advisory-board/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["BK7141","EVE","EVE.AU"],"gpt_icon":0},{"id":"2553442130","title":"BRIEF-EVE Health Confirms Australian Regulatory Path For Initial Access To ED & Dysmenorrhoea Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2553442130","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553442130?lang=en_us&edition=fundamental","pubTime":"2025-07-21 09:35","pubTimestamp":1753061703,"startTime":"0","endTime":"0","summary":"BRIEF-EVE Health Confirms Australian Regulatory Path For Initial Access To ED & Dysmenorrhoea ProductsJuly 21  - Eve Health Group Ltd EVE.AX:AUSTRALIAN REGULATORY PATH CONFIRMED FOR INITIAL ACCESS TO ED & DYSMENORRHOEA PRODUCTSCOMMERCIAL ROLLOUT IN AUSTRALIA EXPECTED TO COMMENCE BEFORE END OF 2025Further company coverage: EVE.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250721:nFWN3TF1QU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVE.AU","BK7141"],"gpt_icon":0},{"id":"2553442375","title":"BUZZ-Australia's EVE Health Group jumps on snagging regulatory wins","url":"https://stock-news.laohu8.com/highlight/detail?id=2553442375","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553442375?lang=en_us&edition=fundamental","pubTime":"2025-07-21 09:20","pubTimestamp":1753060817,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's EVE Health Group jumps on snagging regulatory wins** Shares of EVE Health Group EVE.AX rise 6.7% to A$0.032, their biggest intraday pct gain since July 4** The pharma co satisfies the regulatory requirements to enable prescription access to its Libbo and Dyspro products in Australia** Company to now proceed with commercial launch earlier than anticipated ** Libbo is an oral soluble film containing tadalafil, while Dyspro is a cannabinoid-based pastille formulation** YTD, shares down 20%","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250721:nL4N3TI019:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVE.AU","BK7141"],"gpt_icon":0},{"id":"2549121371","title":"ASX ALERT-EVE Submits First Commercial Purchase Order for Dyspro-EVE.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2549121371","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549121371?lang=en_us&edition=fundamental","pubTime":"2025-07-07 06:49","pubTimestamp":1751842166,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250706:nASX15bwxl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250706:nASXsZZFn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVE.AU","BK7141"],"gpt_icon":0},{"id":"2546271133","title":"Application for quotation of securities - EVE-EVE.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2546271133","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546271133?lang=en_us&edition=fundamental","pubTime":"2025-06-26 10:45","pubTimestamp":1750905911,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250626:nASX3kqH51","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nASX4n45KN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVE.AU","BK7141"],"gpt_icon":0},{"id":"2546711362","title":"Completion of Share Purchase Plan-EVE.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2546711362","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546711362?lang=en_us&edition=fundamental","pubTime":"2025-06-26 10:45","pubTimestamp":1750905903,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250626:nASX4MlfT3","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nASX5832p1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7141","EVE.AU"],"gpt_icon":0},{"id":"2543107306","title":"BRIEF-Eve Health Says Nextract Signed An Agreement With Teledocs Clinic & Consulting","url":"https://stock-news.laohu8.com/highlight/detail?id=2543107306","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543107306?lang=en_us&edition=fundamental","pubTime":"2025-06-16 09:25","pubTimestamp":1750037147,"startTime":"0","endTime":"0","summary":"BRIEF-Eve Health Says Nextract Signed An Agreement With Teledocs Clinic & ConsultingJune 16 (Reuters) - Eve Health Group Ltd EVE.AX:NEXTRACT SIGNED AN AGREEMENT WITH TELEDOCS CLINIC & CONSULTINGAGREEM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nFWN3SG0K5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVE.AU","BK7141"],"gpt_icon":0},{"id":"2543578217","title":"EVE Investor Webinar-EVE.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2543578217","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543578217?lang=en_us&edition=fundamental","pubTime":"2025-06-13 09:23","pubTimestamp":1749777817,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250613:nASX8c9qY9","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250613:nASX3nppdK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7141","EVE.AU"],"gpt_icon":0},{"id":"2542561591","title":"EVE Health Group Completes Nextract Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2542561591","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542561591?lang=en_us&edition=fundamental","pubTime":"2025-06-12 13:43","pubTimestamp":1749707039,"startTime":"0","endTime":"0","summary":"EVE Health Group  completed the acquisition of Nextract after the deal was settled through the issue of 83.3 million fully paid ordinary shares in the firm at a post-consolidation price of AU$0.036 per share, according to a Thursday Australian bourse filing.It also completed a AU$1 million placement to sophisticated and professional investors, issuing 27.8 million shares at the same price, with the proceeds to fund the integration, initial manufacturing scale-up, and regulatory submissions for Nextract.It also opened its share purchase plan for existing shareholders to raise up to AU$500,000.Further, the company appointed Stuart Gunzburg as its Chief Scientific Officer.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7141","EVE","EVE.AU"],"gpt_icon":0},{"id":"2540750039","title":"EVE Health Group Starts Stability Testing for Erectile Dysfunction, Dysmenorrhea Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2540750039","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540750039?lang=en_us&edition=fundamental","pubTime":"2025-06-02 14:41","pubTimestamp":1748846483,"startTime":"0","endTime":"0","summary":"EVE Health Group  said it started stability testing for its treatment candidates for erectile dysfunction and dysmenorrhea, according to a Monday Australian bourse filing.The treatment candidates are in oral formulations, developed by Nextract.Results from the testing will form a component of the technical dossier submitted to the Therapeutic Goods Administration, the filing said.The company plans to submit both products for review in the coming months, and it expects to receive approvals before the end of the current year, per the filing. It completed registration with the Therapeutic Goods Administration as both a registered sponsor and a registered manufacturer.EVE Health Group's acquisition of Nextract is expected to be completed on or around June 12, the filing said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EVE","BK7141","EVE.AU"],"gpt_icon":0},{"id":"2539407780","title":"BRIEF-Eve Health Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2539407780","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539407780?lang=en_us&edition=fundamental","pubTime":"2025-05-29 07:27","pubTimestamp":1748474869,"startTime":"0","endTime":"0","summary":"BRIEF-Eve Health Seeks Trading HaltMay 29 (Reuters) - Eve Health Group Ltd EVE.AX:SEEKS TRADING HALT PENDING ANNOUNCEMENT ON RESULTS OF ITS GENERAL MEETINGFurther company coverage: EVE.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nFWN3S024H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7141","EVE.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}]}}